Horizon Investments’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.43M Buy
63,778
+17,655
+38% +$1.83M 0.07% 233
2026
Q1
$4.45M Buy
46,123
+9,145
+25% +$938K 0.05% 309
2025
Q4
$3.92M Sell
36,978
-18,790
-34% -$2.18M 0.05% 304
2025
Q3
$7.07M Buy
55,768
+6,336
+13% +$754K 0.09% 183
2025
Q2
$6.05M Buy
49,432
+49,409
+214,822% +$5.64M 0.1% 171
2025
Q1
$2.33K Hold
23
– – ﹤0.01% 715
2024
Q4
$2.12K Hold
23
– – ﹤0.01% 724
2024
Q3
$2.22K Buy
23
+6
+35% +$539 ﹤0.01% 701
2024
Q2
$1.46K Hold
17
– – ﹤0.01% 713
2024
Q1
$1.4K Buy
17
+11
+183% +$806 ﹤0.01% 704
2023
Q4
$400 Buy
6
+3
+100% +$194 ﹤0.01% 762
2023
Q3
$201 Hold
3
– – ﹤0.01% 789
2023
Q2
$203 Buy
+3
New +$188 ﹤0.01% 764

Other funds holding EHC

Horizon Investments's EHC Position: Q2 2026 in Review

Horizon Investments increased its Encompass Health (EHC) stake by 38% in Q2 2026, buying an estimated $1.83M and bringing the position to 63,778 shares worth $6.43M. The position accounts for 0.07% of the portfolio, ranked #233.

Horizon Investments first reported a position in EHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.07M in Q3 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Horizon Investments held 63,778 shares of Encompass Health worth $6.43M as of Q2 2026.
  • Horizon Investments bought 17,655 Encompass Health shares in Q2 2026, an estimated $1.83M.
  • Encompass Health made up 0.07% of Horizon Investments's portfolio in Q2 2026, its #233 holding.
  • Horizon Investments first reported a position in Encompass Health in Q2 2023 and has held it in 13 quarters since.
  • Horizon Investments's Encompass Health position peaked at $7.07M in Q3 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.